CVRx, Inc. CVRX
NASDAQ CVRX
$0.61 -0.02 (-3.17%)
At close: Nov 13, 2026 · 4:00 PM EST

CVRx (CVRX) Gains from Sales and Divestitures (2023 - 2026)

Updated

CVRx's Gains from Sales and Divestitures was -$1,000 in Q1 2026.

Analysis

CVRx (CVRX) Gains from Sales and Divestitures (2023 - 2026) Analysis & Trends

For FY2025, Gains from Sales and Divestitures at CVRx came in at -$86,000.

  • In earlier years, Gains from Sales and Divestitures was -$4,000 in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 259.44 Bn 236.08 Bn 5.13 Bn
2 Abbott Laboratories 187.98 Bn 162.45 Bn 7.39 Bn
3 Danaher 163.91 Bn 143.58 Bn 3.84 Bn
4 Intuitive Surgical 153.75 Bn 134.17 Bn 2.08 Bn
5 Medtronic 131.67 Bn 97.80 Bn 6.34 Bn
6 Stryker 117.84 Bn 104.03 Bn 4.25 Bn
7 Boston Scientific 64.27 Bn 59.95 Bn 3.43 Bn
8 Edwards Lifesciences 61.69 Bn 45.00 Bn 1.35 Bn
9 Medline 51.94 Bn 49.07 Bn 1.93 Bn
10 CVRx 17.38 Mn -253.97 Mn 12.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -1,000.00
Dec 31, 2025 -86,000.00
Mar 31, 2023 -4,000.00
API Access

CVRx Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=CVRX&period=max&api_key=YOUR_API_KEY